Drugs / Pneumonococcal Polysaccharide Vaccine 23-valent (PPSV-23)
Pneumonococcal Polysaccharide Vaccine 23-valent (PPSV-23)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02719379 | Apr 2016 → Jun 2017 | asthma | Rohit Divekar | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pneumonococcal Polysaccharide Vaccine 23-valent (PPSV-23) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02719379 ↗ |
| Modality | Vaccine | “PPSV23 vaccine” NCT02719379 ↗ |